Tickerplace logo

Tickerplace

Neurocrine Biosciences, Inc. logo

NBIXNeurocrine Biosciences, Inc.

NBIX Stock Price, Valuation & Chart | Neurocrine Biosciences, Inc.

Compare
$135.71-1.24 (-0.91%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
OverviewFinancialsDividendsRatios

NBIX Historical price chart

NBIX Key Stats

Market Capitalization13.79B
PE Ratio19.61
EPS6.92
Trading Volume1.08M
Today's High/Low138.25/135.55
Dividend Yield0.00
52 Week High/Low186.12/122.14
Shares Outstanding101.65M
NBIX Financial Statement
NBIX Analyst ratings
NBIX Analysis & performance metrics

NBIX Company profile

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes…

NBIX Management team

Management
Julie S. Cooke
Chief Human Resources Officer
Kyle W. Gano Ph.D.CEO
Chief Executive Officer & Director
Lawrence Steinman BA, M.D., Ph.D.
Co-Founder of Neurocrine
Jane Sorensen
Head of Investor Relations
Jude Onyia Ph.D.
Chief Scientific Officer
Eric S. Benevich
Chief Commercial Officer
Wylie W. Vale Ph.D.
Co-Founder
Matthew C. Abernethy CPACFO
Chief Financial Officer
Total 8 executives

NBIX Frequently asked questions

What is Neurocrine Biosciences, Inc. (NBIX) Stock Price?

Current stock price of Neurocrine Biosciences, Inc. (NBIX) stock is $135.71. The stock price is -0.91% lower in the session. The intraday range can be seen from this page. Volume of Neurocrine Biosciences, Inc. (NBIX) stock is 1.08M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Neurocrine Biosciences, Inc. (NBIX) stock price going up or down today?

The stock price of Neurocrine Biosciences, Inc. (NBIX) can change with earnings, company news, and overall market sentiment. Neurocrine Biosciences, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Neurocrine Biosciences, Inc. stock expensive at its current price?

Whether Neurocrine Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NBIX on this page is 19.61. EPS on this page is 6.92. Compare those figures with peers and growth expectations before deciding if the current Neurocrine Biosciences, Inc. price is justified.

How has the stock price of Neurocrine Biosciences, Inc. (NBIX) performed historically?

Historical performance for Neurocrine Biosciences, Inc. (NBIX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NBIX reacted to past earnings and market events.

Should I buy Neurocrine Biosciences, Inc. (NBIX) stock, at this price?

Buying Neurocrine Biosciences, Inc. (NBIX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.